← Back to Patent Explorer
US4518589A Expired / Lapsed US ⏱️ 0.0 years remaining

BBM-2478 Antibiotic complex

Assignee: Bristol Myers Co
•
Filing: 1983-10-03
•
Granted: 1985-05-21
•
Expires: 2003-10-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel antibiotic complex designated BBM-2478 is produced by fermentation of an actinomycete strain J907-21 (ATCC 39417). The complex may be separated chromatographically into two bioactive components designated BBM-2478A and BBM-2478B. The BBM-2478A component displays both antibacterial and antitumor activity while the BBM-2478B component has antibacterial activity.

Inventors

  • 👤 Masataka Konishi
  • 👤 Koko Sugawara
  • 👤 Takeo Miyaki
  • 👤 Hiroshi Kawaguchi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 10:27
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; A; A61; A61P; A61P31/00; A61P31/04; A61P35/00; C12; C12N; C12N1/00; C12N1/20; C12N1/205; C12P; C12P19/00; C12P19/44; C12P19/60; C12R; C12R2001/00; C12R2001/01; C12R2001/465

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 7 words
The antibiotic BBM-2478A having the formula ##STR9##
Claim 2
Dependent Claim 7 words
The antibiotic BBM-2478A having the formula ##STR9##
Claim 3
Dependent Claim 7 words
The antibiotic BBM-2478B having the formula ##STR10##
Claim 4
Dependent Claim 7 words
The antibiotic BBM-2478B having the formula ##STR10##
Claim 5
Dependent Claim 30 words
A method for therapeutically treating an animal host affected by a bacterial infection which comprises administering to said host an effective antibacterial dose of BBM-2478A as defined in claim 1.
Claim 6
Dependent Claim 30 words
A method for therapeutically treating an animal host affected by a bacterial infection which comprises administering to said host an effective antibacterial dose of BBM-2478B as defined in claim 2.
Claim 7
Dependent Claim 39 words
A method for therapeutically treating a mammalian host affected by a malignant tumor selected from P388 leukemia, L1210 leukemia or B16 melanoma which comprises administering to said host an effective tumor-inhibiting dose of BBM-2478A as defined in claim 1.
Claim 8
Dependent Claim 23 words
A pharmaceutical composition comprising an effective antibacterial amount of BBM-2478A as defined in claim 1 in combination with a pharmaceutical carrier or diluent.
Claim 9
Dependent Claim 23 words
A pharmaceutical composition comprising an effective antibacterial amount of BBM-2478B as defined in claim 2 in combination with a pharmaceutical carrier or diluent.
Claim 10
Dependent Claim 43 words
A pharmaceutical composition for treatment of a mammalian host affected by a malignant tumor selected from P388 leukemia, L1210 leukemia or B16 melanoma comprising an effective tumor-inhibiting amount of BBM-2478A as defined in claim 1 in combination with a pharmaceutical carrier or diluent.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-05-20 1988-11-19 1989-05-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-05-20 1992-11-19 1993-05-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-05-20 1996-11-19 1997-05-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag